Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
12-1
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #577
advertisement
Journal of Ocular Pharmacology and Therapeutics
10
Showing records 1 to 10 |
Display all abstracts in
Journal of Ocular Pharmacology and Therapeutics
25421
Ocular hypotensive effects of anti-glaucoma agents in mice
Akaishi T; Odani-Kawabata N; Ishida N; Nakamura M
Journal of Ocular Pharmacology and Therapeutics
2009; 25: 401-407
25422
Intravitreal bevacizumab for neovascular glaucoma
Vasudev D; Blair M P; Galasso J; Kapur R; Vajaranant T
Journal of Ocular Pharmacology and Therapeutics
2009; 25: 453-458
25423
Central corneal thickness during treatment with travoprost 0.004% in glaucoma patients
Schlote T; Tzamalis A; Kynigopoulos M
Journal of Ocular Pharmacology and Therapeutics
2009; 25: 459-462
25535
A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
Facio A C; Reis A S; Vidal K S; de Moraes C G; Suzuki R; Hatanaka M; Susanna R
Journal of Ocular Pharmacology and Therapeutics
2009; 25: 447-451
25424
Bilateral deepening of upper lid sulcus from topical bimatoprost therapy
Yam J C S; Yuen N S Y; Chan C W N
Journal of Ocular Pharmacology and Therapeutics
2009; 25: 471-472
25418
Effects of timolol and latanoprost on respiratory and cardiovascular status in elderly patients with glaucoma
Ergin A; Ornek K; Gullu R; Bulcun E; Ekici M; Ekici A
Journal of Ocular Pharmacology and Therapeutics
2009; 25: 463-466
25425
Intraocular pressure (IOP) reduction by latanoprost in japanese normal tension glaucoma patients over a five-year period stratified by presenting IOP
Tsuda M; Ando A; Matsuyama K; Otsuji T; Fukui C; Maenishi N; Kuwahara A; Nishimura T; Jo N; Nambu H
Journal of Ocular Pharmacology and Therapeutics
2009; 25: 441-445
25426
Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: A 3-month, open-label, replacement study in glaucoma patients
Nguyen Q H; Earl M
Journal of Ocular Pharmacology and Therapeutics
2009; 25: 541-544
25420
Comparative study of topical application of timolol and verapamil in patients with glaucoma within 6 months
Shayegan M R; Boloorian A A; Kianoush S
Journal of Ocular Pharmacology and Therapeutics
2009; 25: 551-553
25419
Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs
Schwartz G F; Tan J; Kotak S
Journal of Ocular Pharmacology and Therapeutics
2009; 25: 555-561
Issue
12-1
Table of Contents
Editor's Selection
Change Issue
24-2 (2024)
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement